PD-L1 tumor expression is associated with poor prognosis and systemic immunosuppression in glioblastoma.

PURPOSE: Glioblastoma is the most common primary malignant brain tumor in the adult, whose grim prognosis largely relates to the absence of effective treatment targets. Given its success in other cancers, immunotherapy has been trialed in glioblastoma and failed to demonstrate the expected benefit. Importantly, these disappointing results highlight the importance of understanding the unique and transforming biology of glioblastoma and its microenvironment. Our goal was to evaluate and characterize the expression of PD-L1 through immunohistochemistry in a large glioblastoma cohort. We further studied PD-L1 expression-associated prognosis and its correlation to systemic and neuropathological parameters. METHODS: A series of 352 glioblastoma specimens (313 initial resection, 39 matched recurrences) was collected, with a detailed characterization of tumor neuropathological characteristics, including the presence, density and location of tumor infiltrating lymphocytes (TIL). Two hematological markers, absolute lymphocyte count and neutrophil-lymphocyte ratio (NLR), were used to analyze and correlate with systemic inflammation and immunosuppression. Immunohistochemistry was performed to evaluate PD-L1 expression. RESULTS: Membranous PD-L1 expression was identified in 31% (98/313) of newly diagnosed and 46% (18/39) of matched recurrent tumors. TIL were found in 26% (82/313) of primary tumors and both density and location were found to be significantly associated with PD-L1 expression (p < 0.001). Interestingly, PD-L1 expressing tumors had more frequently areas with sarcomatous differentiation (p < 0.001) and were significantly associated with lower lymphocyte count (p = 0.018) and higher NLR ratio (p = 0.004) upon diagnosis. Importantly, PD-L1 expression was an independent poor prognostic marker in our cohort. CONCLUSION: Taken together, our data points to a putative role for PD-L1 expression in glioblastoma biology, which correlates to poor patient overall survival, as well as with a general systemic inflammatory status and immunosuppression.

Brain biopsy in suspected non-neoplastic neurological disease.

Brain biopsy has a well-established role in the diagnosis of CNS neoplasia. Nevertheless, despite being essential for the diagnosis of some benign neurological diseases, little consensus exists regarding its indications for disease diagnosis and patient orientation. Our aim was to assess brain biopsy diagnostic yield in patients with neurological deterioration of unknown etiology, to identify the clinical characteristics associated with an increased likelihood of achieving a diagnostic biopsy as well as the characteristics linked to a particular diagnosis. METHODS: A retrospective analysis of 62 consecutive brain biopsies performed at a single tertiary care center between January 2004 and December 2015 for suspected non-neoplastic neurological disease was performed. The clinical presentation, imaging, and laboratory results were collected and compared between diagnostic groups. RESULTS: Sixty-eight percent of the biopsies led to a definitive diagnosis. The most common histological diagnosis was central nervous system lymphoma (eight cases), followed by astrocytoma, demyelinating disease, and progressive multifocal leukoencephalopathy (four cases each). No clinical characteristics were found to predict a diagnostic biopsy or to correlate with a specific diagnosis. Importantly, a distinct diagnosis from the initially suspected was achieved in 52% of cases and biopsy findings led to a change of therapeutic orientation in 78% of the cases. CONCLUSIONS: Our results suggest that brain biopsies have a significant impact on patient management and should be considered early in selected cases in which less invasive testing was unable to reach a definitive diagnosis.

Supratentorial hemangioblastomas in von Hippel-Lindau wild-type patients - case series and literature review.

BACKGROUND: Supratentorial hemangioblastoma is an uncommon lesion with few data available. Resemblance to other tumours represents a struggle concerning pre-operative diagnosis and management. OBJECTIVES: The aim of this study was to review the current literature, integrating two new cases with uncommon features. METHODS: A search of English language peer-reviewed articles in PubMed®, Cochrane Library®, Google Scholar® and summary of the current knowledge. RESULTS: A total of 162 cases, with no predominance between von Hippel-Lindau disease and wild-type sporadic lesions. The frontal lobe is the most common topography, followed by the pituitary stalk, with image resemblance to a glioma or a metastasis. From these, 20 cases revealed dural attachment, mimicking a meningioma. Symptoms are due to mass effect or epilepsy, with low haemorrhagic risk. Clinical outcome on supratentorial hemangioblastoma depends on resection extension, with no recognised complementary treatment. Post-operative follow-up is essential, even in wild-type, sporadic cases, concerning recent reports of tumour dissemination. CONCLUSIONS: This review compiles the main characteristics of supratentorial hemangioblastoma, that despite its rarity, should be a concern on differential diagnosis, treatment planning and expected prognosis.

Expanded and Wild-type Ataxin-3 Modify the Redox Status of SH-SY5Y Cells Overexpressing α-Synuclein.

Neurodegenerative diseases are considered to be distinct clinical entities, although they share the formation of proteinaceous aggregates and several neuropathological mechanisms. Increasing evidence suggest a possible interaction between proteins that have been classically associated to distinct neurodegenerative diseases. Thus, common molecular and cellular pathways might explain similarities between disease phenotypes. Interestingly, the characteristic Parkinson's disease (PD) phenotype linked to bradykinesia is also a clinical presentation of other neurodegenerative diseases. An example is Machado-Joseph disease (MJD), with some patients presenting parkinsonism and a positive response to levodopa (L-DOPA). Protein aggregates positive for α-synuclein (α-Syn), a protein associated with PD, in the substantia nigra of MJD models made us hypothesize a putative additive biological effect induced by expression of α-Syn and ataxin-3 (Atx3), the protein affected in MJD. Hence, in this study we analysed the influence of these two proteins (α-Syn and wild-type or mutant Atx3) on modified redox signaling, a pathological process potentially linked to both diseases, and also the impact of exposure to iron and rotenone in SH-SY5Y neuroblastoma cells. Our results show that both α-Syn and mutant Atx3 overexpression per se increased oxidation of dichlorodihydrofluorescein (DCFH2), and co-expression of these proteins exhibited additive effect on intracellular oxidation, with no correlation with apoptotic features. Mutant Atx3 and α-Syn also potentiated altered redox status induced by iron and rotenone, a hint to how these proteins might influence neuronal dysfunction under pro-oxidant conditions. We further show that overexpression of wild-type Atx3 decreased intracellular DCFH2 oxidation, possibly exerting a neuroprotective role.

Impact of an early mobilization protocol on the reduction of medical complications after surgery for chronic subdural hematoma: the GET-UP Trial.

OBJECTIVE: Timing of mobilization after chronic subdural hematoma (cSDH) surgery is highly heterogeneous among neurosurgical centers. Past studies have suggested that early mobilization may reduce medical complications without increasing recurrence, but evidence remains scarce. The purpose of this study was to compare an early mobilization protocol with a 48-hour bed rest practice, with a focus on the occurrence of medical complications. METHODS: The GET-UP Trial is a prospective, randomized, unicentric, open-label study with an intention-to-treat primary analysis designed to evaluate the impact of an early mobilization protocol after burr hole craniostomy for cSDH on the occurrence of medical complications and functional outcomes. A total of 208 patients were recruited and randomly assigned to either an early mobilization group where they began head-of-bed elevation within the first 12 hours after surgery and proceeded to sedestation, orthostatism, and/or walking as rapidly as tolerated, or to a bed rest group where they remained recumbent with a head-of-bed angle inferior to 30° for 48 hours after surgery. The primary outcome was the occurrence of a medical complication (defined as either an infection, seizure, or thrombotic event) after surgery and until clinical discharge. Secondary outcomes included length of stay measured from randomization to clinical discharge, surgical hematoma recurrence at clinical discharge and 1 month after surgery, and Glasgow Outcome Scale-Extended (GOSE) assessment at clinical discharge and 1 month after surgery. RESULTS: A total of 104 patients were randomly assigned to each group. No significant baseline clinical differences were observed before randomization. The primary outcome occurred in 36 (34.6%) patients included in the bed rest group and 20 (19.2%) in the early mobilization group (p = 0.012). At 1 month after surgery, a favorable functional outcome (defined as GOSE score ≥ 5) was observed in 75 (72.1%) patients in the bed rest group and 85 (81.7%) in the early mobilization group (p = 0.100). Surgical recurrence occurred in 5 (4.8%) patients in the bed rest group and 8 (7.7%) in the early mobilization group (p = 0.390). CONCLUSIONS: The GET-UP Trial is the first randomized clinical trial to assess the impact of mobilization strategies on medical complications after burr hole craniostomy for cSDH. Early mobilization was associated with a reduction in medical complications without a significant effect on surgical recurrence, compared with a 48-hour bed rest protocol.

GET-UP Trial 1-year results: long-term impact of an early mobilization protocol on functional performance after surgery for chronic subdural hematoma.

OBJECTIVE: Evidence on timing for mobilization after chronic subdural hematoma (cSDH) surgery is heterogeneous, and practices differ considerably among neurosurgical centers. The Impact of an Early Out-of-Bed Paradigm in Postoperative Outcomes of Chronic Subdural Hematomas: GET-UP Randomized Prospective Trial (GET-UP Trial) is a randomized clinical trial comparing a postoperative early mobilization protocol to bed rest. Previously reported results at clinical discharge and 1 month after surgery indicated a decreased risk of medical complications in the early mobilization group. Herein, the authors report outcomes at the 1-year follow-up. METHODS: The GET-UP Trial is a prospective, randomized, unicentric, open-label study with an intention-to-treat primary analysis designed to evaluate the impact of an early mobilization protocol after burr hole craniostomy for cSDH on the occurrence of medical complications and functional outcomes. Between January 2019 and August 2021, a total of 208 patients were recruited and randomized to either an early mobilization group, in which patients began elevation of the head of the bed within the first 12 hours after surgery, or to a bed rest group, in which patients remained recumbent for 48 hours. Outcomes assessed at the 1-year follow-up included functional status as measured by the Glasgow Outcome Scale-Extended (GOSE) and repeat surgery for hematoma recurrence (surgical recurrence). RESULTS: A total of 203 patients completed 1 year of follow-up: 101 in the bed rest group and 102 in the early mobilization group. No significant baseline pre-randomization clinical differences were observed between the two management groups. At 1 year after surgery, a favorable functional outcome, defined as a GOSE score ≥ 5, was observed in 59 patients (58.4%) in the bed rest group and 78 (76.5%) in the early mobilization group (p = 0.006). Death occurred in 25 patients (24.8%) in the bed rest group and 16 (15.7%) in the early mobilization group (p = 0.108). Surgical recurrence was noted in 6 patients (5.9%) in the bed rest group and 7 (6.9%) in the early mobilization group (p = 0.788). Multivariate analysis showed an independent association between early mobilization and an increase in favorable functional outcomes (OR 2.006, 95% CI 1.076-3.739, p = 0.028). CONCLUSIONS: The GET-UP Trial is the first randomized clinical trial assessing the impact of mobilization strategies on medical complications after burr hole craniostomy for cSDH. Regarding functional results 1 year after surgery, early mobilization was associated with an improvement in functional outcomes without an increase in surgical recurrence. These findings support the preference for an early mobilization protocol in cSDH patients over mandatory bed rest strategies.

T2-FLAIR mismatch sign: a roadmap of pearls and pitfalls.

T2-FLAIR mismatch sign has been advocated to be 100% specific for IDH-mutant 1p/19q non-codeleted gliomas (diffuse astrocytomas). However, false positives have been reported in recent works. Loose application of the criteria may lead to erroneous classification, especially by non-trained neuroradiologists. In this pictorial essay, we aim to bring attention to the need for strict criteria for the application of T2-FLAIR mismatch sign and to discuss the potential pitfalls in the application of these criteria. For that, a series of adult brain tumour cases are presented to demonstrate how to apply this radiological sign in the clinical practice.

Production of methylcellulose films functionalized with poly-ε-caprolactone nanocapsules entrapped ß-carotene for food packaging application.

Nowadays, there is a worldwide demand in the production of innovative packaging that release active compounds to increase the shelf life of perishable food products. Therefore, this study produced methylcellulose films functionalized with poly-ε-caprolactone nanocapsules entrapped ß-carotene. The nanoparticles were produced by the nanoprecipitation method, and 10, 30, and 50 % of nanoparticles colloidal solution was added in the methylcellulose filmogenic solution. The films were characterized by the mechanical, physicochemical properties, antioxidant activity, and release of ß-carotene from the polymeric matrix to a food simulant. The results demonstrated satisfactory mechanical properties; however, the addition of nanoparticles decreased the Young's Modulus and increased the elongation at break. Regarding light transmission, the incorporation of ß-carotene nanoparticles promoted a decrease in the percentage of ultraviolet ray's transmittance through the film matrix, as well as visible light. The incorporation of nanoparticles improved the antioxidant activity of the films, which was proportional to the concentration of ß-carotene used in the formulation. The release of ß-carotene reached a maximum value of 10.93 µg g-1 film containing 70 % nanoparticles, which was a desired profile for food application. Finally, the methylcellulose films functionalized with poly-ε-caprolactone nanocapsules can release ß-carotene, and therefore, can be considered as a novel nanomaterial for food conservation, with a potential to increase the shelf life of perishable food products.

Cadherin Expression and EMT: A Focus on Gliomas.

Cadherins are calcium-binding proteins with a pivotal role in cell adhesion and tissue homeostasis. The cadherin-dependent mechanisms of cell adhesion and migration are exploited by cancer cells, contributing to tumor invasiveness and dissemination. In particular, cadherin switch is a hallmark of epithelial to mesenchymal transition, a complex development process vastly described in the progression of most epithelial cancers. This is characterized by drastic changes in cell polarity, adhesion, and motility, which lead from an E-cadherin positive differentiated epithelial state into a dedifferentiated mesenchymal-like state, prone to metastization and defined by N-cadherin expression. Although vastly explored in epithelial cancers, how these mechanisms contribute to the pathogenesis of other non-epithelial tumor types is poorly understood. Herein, the current knowledge on cadherin expression in normal development in parallel to tumor pathogenesis is reviewed, focusing on epithelial to mesenchymal transition. Emphasis is taken in the unascertained cadherin expression in CNS tumors, particularly in gliomas, where the potential contribution of an epithelial-to-mesenchymal-like process to glioma genesis and how this may be associated with changes in cadherin expression is discussed.

HIPTCN: Prospective Observational Study of Hypocoagulated Head Trauma Patients with Normal Admission Computed Tomography Scan.

INTRODUCTION: Our national protocol for traumatic brain injury dictates that hypocoagulated patients with mild trauma and initial tomography scan with no intracranial traumatic changes must be hospitalized for 24 hours and do a post-surveillance tomography scan. The main goal of this study was to evaluate the clinical relevance of these measures. MATERIAL AND METHODS: A prospective observational study was undertaken in four hospitals. Adult hypocoagulated traumatic brain injury patients with a normal tomography scan were included. The main outcomes evaluated were rate of delayed intracranial hemorrhage, rate of admission in a neurosurgical department, rate of complications related with surveillance and rate of prolonged hospitalization due to complications. An analysis combining data from a previously published report was also done. RESULTS: A total of 178 patients were included. Four patients (2.3%) had a delayed hemorrhage and three (1.7%) were hospitalized in a neurosurgery ward. No cases of symptomatic hemorrhage were identified. No surgery was needed, and all patients had their anticoagulation stopped. Complications during surveillance were reported in seven patients (3.9%), of which two required prolonged hospitalization. DISCUSSION: The rate of complications related with surveillance was higher than the rate of delayed hemorrhages. The initial period of in-hospital surveillance did not convey any advantage since the management of patients was never dictated by neurological changes. Post-surveillance tomography played a role in deciding about anticoagulation suspension and prolongation of hospitalization. CONCLUSION: Delayed hemorrhage is a rare event and the need for surgery even rarer. The need for in-hospital surveillance should be reassessed.

Introdução: O nosso protocolo nacional para traumatismos cranioencefálicos recomenda que doentes hipocoagulados com trauma craniano ligeiro e tomografia inicial sem alterações traumáticas intracranianas sejam hospitalizados 24 horas e façam uma tomografia computorizada pós-vigilância. O principal objetivo deste estudo foi avaliar a relevância clínica dessas medidas. Material e Métodos: Foi realizado em quatro hospitais um estudo prospetivo e observacional. Foram incluídos adultos hipocoagulados com trauma craniano e tomografia normal. Os principais outcomes avaliados foram: taxa de hemorragia intracraniana tardia, taxa de internamento numa enfermaria de neurocirurgia, taxa de complicações relacionadas com a vigilância e taxa de hospitalização prolongada por complicações. Resultados: Foram incluídos um total de 178 doentes. Quatro doentes (2,3%) apresentaram hemorragia tardia e três (1,7%) foram mantidos hospitalizados numa enfermaria de Neurocirurgia. Não foram documentados casos de hemorragia tardia sintomática. Nenhuma cirurgia foi necessária e em todos estes doentes a anticoagulação foi interrompida. Durante a vigilância, foram relatadas complicações em sete doentes (3,9%), dos quais dois exigiram hospitalização prolongada. Discussão: A taxa de complicações relacionadas com a vigilância foi maior do que a taxa de hemorragia tardia. O período inicial de vigilância intra-hospitalar não trouxe qualquer vantagem, já que o manejo dos doentes nunca foi ditado por alterações neurológicas. A tomografia pós-vigilância desempenhou um papel importante na decisão sobre a suspensão da anticoagulação e o prolongamento da hospitalização. Conclusão: A hemorragia tardia é um evento raro e a necessidade de cirurgia ainda mais. Deve ser reavaliada a necessidade de vigilância intra-hospitalar.

Antioxidant and antimicrobial methylcellulose films containing Lippia alba extract and silver nanoparticles.

Methylcellulose is a biopolymer, which can be used in the preparation of films for the production of biodegradable active packaging. In this work, the methylcellulose films containing biosynthesized silver nanoparticles (AgNPs) were developed using Lippia alba extract. The physico-chemical, antioxidant, and antimicrobial properties of the films were studied. The insertion of Lippia alba compounds was verified using infrared spectroscopy (FTIR), with the appearance of a band at 1595 cm-1 and 1410 cm-1 which is characteristic of CCC stretches of the aromatic ring, and the increase in the hydrophobicity of the films containing the extract in relation to the control film. The films containing AgNPs presented a decrease in tensile strength and elastic modulus, but increased elongation. It was observed that the films that contain AgNPs presented superior antioxidant activity compared to the other films, besides antimicrobial activity against the tested microorganisms.

Development and Characterization of Poly-ε -caprolactone Nanocapsules Containing β -carotene Using the Nanoprecipitation Method and Optimized by Response Surface Methodology

Abstract Nanoparticles demonstrate an important role in the protection of bioactive compounds from external factors such as temperature, oxygen and light. In this study, poly-ε-caprolactone (PCL) nanoparticles entrapped β-carotene was produced using the nanoprecipitation method. Firstly, was evaluated the lipophilic surfactant effect and carrier agent of the active compound in the nanocapsules formulation. After choosing the most stable formulation, the nanocapsules production was optimized using β-carotene, caprylic/capric triglycerides (CCT) and soybean lecithin. Response surface methodology (RSM) was adopted to evaluate the influence of soy lecithin concentration, volume of CCT and β-carotene concentration in the particle size, zeta potential, polydispersity index (PDI), encapsulation efficiency and recovery. Formulations containing soy lecithin and CCT demonstrated better stability comparing to the other formulations tested. The nanoparticle formulations presented an optimized particle size below 200 nm, PDI lower than 0.1 and encapsulation efficiency above 95%. Based on the results obtained, the optimum conditions to prepare PCL nanocapsules were 0.2160 mg/mL of β-carotene, 232.42 μL of CCT and 2.59 mg/mL of soy lecithin, suggesting an applicability to promote controlled released of β-carotene in food system.

Characterization of antioxidant methylcellulose film incorporated with α-tocopherol nanocapsules.

Biodegradable and antioxidant films based on methylcellulose (MC) and α-tocopherol nanocapsule suspension (NCs) were developed. MC and NCs films were prepared by a casting method in three different proportions. The mechanical, wettability, colour, light transmission, antioxidant and release characteristics of the films were studied. The addition of NCs to MC films decreased the tensile strength (TS) and the elastic modulus (EM) (p<0.05) but increased the percentage elongation at break (%E) and thickness (p<0.05). NCs films showed a higher hydrophobicity when compared to that of film control. Lightness and yellowish color were intensified in the NCs films which, in their turn, demonstrated high antioxidant activity and excellent barrier properties against UV and visible light. A burst and prolonged release of α-tocopherol to food simulant was also reported.

Evaluation of oxidative stability of mayonnaise containing poly ε- caprolactone nanoparticles loaded with thyme essential oil

Suspensions of poly ε-caprolactone (PCL) nanoparticles loaded with thyme essential oil were prepared as a natural antioxidant in mayonnaise. Mean particle size was 204.9 ± 2.7 and 240.0 ± 5.5 nm respectively for nanoparticles prepared with PCL alone (NP-C) and for those loaded with thyme essential oil (NP-T). The polydispersity index indicated a homogeneous distribution of all particles, with no significant difference between NP-C and NP-T samples. The nanoparticles showed a large negative charge evidenced by zeta potential rates, indicating high physical stability. The use of PCL as a polymer provided high encapsulation efficiency for thyme essential oil (91.15 ± 2.12 %). DPPH (2,2-diphenyl-1-picrylhydrazyl) method determined IC50 rates were 476.4 ± 33.6 and 483.5 ± 20.4 µg mL-1respectively for unencapsulated oil and for NP-T, evidencing pronounced antioxidant activity. NP-C, NP-T and synthetic antioxidant butylhydroxytoluene (BHT) were applied to samples of mayonnaise and their oxidative stability evaluated for eight days in an oven at 63 ± 3ºC. Results of hydroperoxide value (HP) and thiobarbituric acid reactive substances (TBARS) showed that NP-T had a similar performance as synthetic antioxidant BHT in the prevention of mayonnaise lipid oxidation

Extração de -glucanas de cevada e caracterização parcial do amido residual

The objective of the study was to evaluate the parameters of the extraction of barley´s -glucans and partially characterize the residual starch after extraction. A method was developed for the extraction of barley -glucans without damaging the residual starch, assessing the variables pH and extraction temperature. The percentage of -glucans in the extracted fraction varied from 44,21 to 53,38% , being influenced by temperature and the extracted starch varied from 65,98% a 77,54%, being influenced by pH. The residual starch from barley's -glucan extraction had a swelling power and solubility of 8.54±0.29% and 6.04±0.07%, respectively. The RVA´s amylograph for this starch showed a maximum viscosity of 164.67±1.30 RVU and breakdown viscosity of 45.79±2.06 RVU. The infrared spectrum of the residual starch was typical of native barley starch and similar to isolated starch from corn, wheat and cassava. According to the scanning electron micrographs fraction of starch, it was possible to see a mixture of large lenticular granules with an average diameter of 19.15µm and small spherically shaped ones, with 4.78µm. The characteristics showed by the residual starch from barley´s -glucan extraction, suggest a possible application in the food industry.

O objetivo do trabalho foi avaliar os parâmetros da extração de -glucanas de cevada e caracterizar parcialmente o amido residual da extração. Foi desenvolvida metodologia para extração de -glucanas de cevada sem degradação do amido, avaliando as variáveis pH e temperatura de extração. O percentual de -glucanas extraída variou de 44,21 a 53,38%, sendo influenciado pela temperatura, e o de amido extraído variou de 65,98% a 77,54%, sendo influenciado pelo pH. O amido residual da extração de -glucanas de cevada apresentou poder de inchamento e solubilidade de 8,54±0,29% e 6,04±0,073%, respectivamente. O amilograma de ARV desse amido apresentou viscosidade máxima de 164,67±1,30 RVU e quebra de viscosidade de 45,79±2,06 RVU. O espectro de infravermelho do amido residual é típico de amido de cevada nativo e semelhante ao de amidos isolados de milho, trigo e mandioca. De acordo com as micrografias eletrônicas de varredura da fração amido, foi possível visualizar uma mistura de grânulos grandes e lenticulares, com um diâmetro médio de 19,15µm e de granulos pequenos com forma esférica, de 4,78µm. As características demonstradas pelo amido residual da extração de -glucanas de cevada sugerem sua viabilidade para utilização na indústria de alimentos.

Extração de -glucanas de cevada e caracterização parcial do amido residual

The objective of the study was to evaluate the parameters of the extraction of barley´s -glucans and partially characterize the residual starch after extraction. A method was developed for the extraction of barley -glucans without damaging the residual starch, assessing the variables pH and extraction temperature. The percentage of -glucans in the extracted fraction varied from 44,21 to 53,38% , being influenced by temperature and the extracted starch varied from 65,98% a 77,54%, being influenced by pH. The residual starch from barley's -glucan extraction had a swelling power and solubility of 8.54±0.29% and 6.04±0.07%, respectively. The RVA´s amylograph for this starch showed a maximum viscosity of 164.67±1.30 RVU and breakdown viscosity of 45.79±2.06 RVU. The infrared spectrum of the residual starch was typical of native barley starch and similar to isolated starch from corn, wheat and cassava. According to the scanning electron micrographs fraction of starch, it was possible to see a mixture of large lenticular granules with an average diameter of 19.15µm and small spherically shaped ones, with 4.78µm. The characteristics showed by the residual starch from barley´s -glucan extraction, suggest a possible application in the food industry.

O objetivo do trabalho foi avaliar os parâmetros da extração de -glucanas de cevada e caracterizar parcialmente o amido residual da extração. Foi desenvolvida metodologia para extração de -glucanas de cevada sem degradação do amido, avaliando as variáveis pH e temperatura de extração. O percentual de -glucanas extraída variou de 44,21 a 53,38%, sendo influenciado pela temperatura, e o de amido extraído variou de 65,98% a 77,54%, sendo influenciado pelo pH. O amido residual da extração de -glucanas de cevada apresentou poder de inchamento e solubilidade de 8,54±0,29% e 6,04±0,073%, respectivamente. O amilograma de ARV desse amido apresentou viscosidade máxima de 164,67±1,30 RVU e quebra de viscosidade de 45,79±2,06 RVU. O espectro de infravermelho do amido residual é típico de amido de cevada nativo e semelhante ao de amidos isolados de milho, trigo e mandioca. De acordo com as micrografias eletrônicas de varredura da fração amido, foi possível visualizar uma mistura de grânulos grandes e lenticulares, com um diâmetro médio de 19,15µm e de granulos pequenos com forma esférica, de 4,78µm. As características demonstradas pelo amido residual da extração de -glucanas de cevada sugerem sua viabilidade para utilização na indústria de alimentos.

Extração de β-glucanas de cevada e caracterização parcial do amido residual / Extraction of barley β-glucans and partial characterization of residual starch

O objetivo do trabalho foi avaliar os parâmetros da extração de β-glucanas de cevada e caracterizar parcialmente o amido residual da extração. Foi desenvolvida metodologia para extração de β-glucanas de cevada sem degradação do amido, avaliando as variáveis pH e temperatura de extração. O percentual de β-glucanas extraída variou de 44,21 a 53,38 por cento, sendo influenciado pela temperatura, e o de amido extraído variou de 65,98 por cento a 77,54 por cento, sendo influenciado pelo pH. O amido residual da extração de β-glucanas de cevada apresentou poder de inchamento e solubilidade de 8,54±0,29 por cento e 6,04±0,073 por cento, respectivamente. O amilograma de ARV desse amido apresentou viscosidade máxima de 164,67±1,30 RVU e quebra de viscosidade de 45,79±2,06 RVU. O espectro de infravermelho do amido residual é típico de amido de cevada nativo e semelhante ao de amidos isolados de milho, trigo e mandioca. De acordo com as micrografias eletrônicas de varredura da fração amido, foi possível visualizar uma mistura de grânulos grandes e lenticulares, com um diâmetro médio de 19,15µm e de granulos pequenos com forma esférica, de 4,78µm. As características demonstradas pelo amido residual da extração de β-glucanas de cevada sugerem sua viabilidade para utilização na indústria de alimentos.

The objective of the study was to evaluate the parameters of the extraction of barley´s β-glucans and partially characterize the residual starch after extraction. A method was developed for the extraction of barley β-glucans without damaging the residual starch, assessing the variables pH and extraction temperature. The percentage of β-glucans in the extracted fraction varied from 44,21 to 53,38 percent , being influenced by temperature and the extracted starch varied from 65,98 percent a 77,54 percent, being influenced by pH. The residual starch from barley's β-glucan extraction had a swelling power and solubility of 8.54±0.29 percent and 6.04±0.07 percent, respectively. The RVA´s amylograph for this starch showed a maximum viscosity of 164.67±1.30 RVU and breakdown viscosity of 45.79±2.06 RVU. The infrared spectrum of the residual starch was typical of native barley starch and similar to isolated starch from corn, wheat and cassava. According to the scanning electron micrographs fraction of starch, it was possible to see a mixture of large lenticular granules with an average diameter of 19.15µm and small spherically shaped ones, with 4.78µm. The characteristics showed by the residual starch from barley´s β-glucan extraction, suggest a possible application in the food industry.